Protagonist Therapeutics Inc buy Truist Financial Co.
Start price
11.03.25
/
50%
€50.50
Target price
11.03.26
€70.01
Performance (%)
62.38%
Price
04.03.26
€82.00
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc has seen massive gains of 62.38%. This prediction currently runs until 11.03.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | 3.797% | 3.797% |
| iShares Core DAX® | -0.975% | -4.716% |
| iShares Nasdaq 100 | 1.163% | 1.881% |
| iShares Nikkei 225® | -1.593% | -5.385% |
| iShares S&P 500 | -0.278% | 0.327% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at Truist Financial Co. from $60.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€75.49
28.10.26
28.10.26
24.24%
04.03.26
04.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
09.09.24
09.09.24
€54.34
09.09.25
09.09.25
4.95%
10.09.25
10.09.25